This study showed that [11C]Martinostat HDAC I reduction was highly associated with elevated amyloid-β and tau in AD, which contrasts with previous studies using experimental disease models that predicted HDAC I increase in living patients with AD2,12,16. The gene discussed is MAPT; the disease is Alzheimer disease.